About Avery Swett
Articles Written by Avery Swett
PE-Backed BioMatrix Infusion Pharmacy Closes Acquisition of LUX Infusion
BioMatrix Infusion Pharmacy, backed by private equity firm Frazier Healthcare Partners, announced the successful acquisition of LUX Infusion, effective October 17, 2025. With this acquisition, BioMatrix extends its reach into the Pacific Northwest. Financial terms of... Read More »
Life Sciences R&D M&A Market Overview: Strategic Buyers Amid a Cooling Market
Despite a recent cooling in Life Sciences R&D, there has been a shift among buyers towards more selective, strategic acquisitions that prioritize quality over quantity. The Life Sciences R&D sector, encompassing clinical trial management, contract research... Read More »
Private Equity Interest on the Rise in Q3:25
In the third quarter of 2025, private equity firms and their sponsored companies (“PE Buyers,” collectively) announced 183 transactions in the healthcare M&A market, or approximately 34.4% of all the 532 announced healthcare deals, according to data captured in... Read More »
Healthcare M&A Activity Increases 7% in Q3:25
Healthcare merger and acquisition activity increased in the third quarter of 2025, with 532 deals announced, according to new acquisition data from LevinPro HC. Activity in Q3:25 was 7% higher than the 495 deals announced in the second quarter, and 3% higher than the... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
